Eyenuk
PrivateLast Round
Seed Round
Jun 22, 2026
Total Funding Raised
$37.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eyenuk is a healthcare technology company that specializes in artificial intelligence-driven eye screening solutions for autonomous disease detection and risk assessment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eyenuk Comparables
Compare Eyenuk with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RETINA-AI Health | 91% | |
| Digital Diagnostics | 91% | |
| AEYE Health | 89% |
Eyenuk Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 22, 2026 | ||||
| Series A | Oct 17, 2022 | ||||
| Convertible Debt | Jul 20, 2021 | ||||
| Grant | Oct 10, 2019 |
Key People
Founding team and executive leadership
Eyenuk Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kendall Capital Partners | Series A |
| KOFA Healthcare | Series A |
| NIH RADx | Grant |
| AXA IM Alts | Convertible Debt, Series A |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| BNP Paribas Asset Management | Convertible Debt, Series A |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Raised $5.6M in seed funding.
- Jan 6, 2025
Gaurav Agarwal appointed as the new Chief Executive Officer.
Eyenuk Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access